Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Aedes | 3 | 2017 | 380 | 0.79 | Why? |
| Murinae | 1 | 2017 | 25 | 0.69 | Why? |
| Mosquito Vectors | 2 | 2017 | 351 | 0.69 | Why? |
| Hantavirus Infections | 1 | 2017 | 62 | 0.64 | Why? |
| Hantavirus | 1 | 2017 | 63 | 0.64 | Why? |
| Chikungunya Fever | 2 | 2017 | 345 | 0.63 | Why? |
| Rodent Diseases | 1 | 2017 | 115 | 0.62 | Why? |
| Mosquito Control | 2 | 2017 | 237 | 0.62 | Why? |
| Insecticides | 1 | 2017 | 178 | 0.60 | Why? |
| Dengue | 2 | 2018 | 1565 | 0.58 | Why? |
| Dengue Virus | 2 | 2018 | 910 | 0.53 | Why? |
| Disease Notification | 1 | 2020 | 639 | 0.53 | Why? |
| Spatio-Temporal Analysis | 1 | 2018 | 1182 | 0.46 | Why? |
| Disease Outbreaks | 6 | 2021 | 27595 | 0.35 | Why? |
| Herpes Zoster | 2 | 2018 | 331 | 0.23 | Why? |
| Italy | 11 | 2021 | 38444 | 0.20 | Why? |
| Population Dynamics | 3 | 2017 | 378 | 0.19 | Why? |
| Herpesvirus 3, Human | 2 | 2018 | 228 | 0.18 | Why? |
| Urban Renewal | 1 | 2017 | 25 | 0.18 | Why? |
| Larva | 1 | 2017 | 153 | 0.17 | Why? |
| Chickenpox Vaccine | 1 | 2018 | 59 | 0.17 | Why? |
| Chikungunya virus | 2 | 2017 | 339 | 0.17 | Why? |
| Models, Theoretical | 5 | 2021 | 6659 | 0.16 | Why? |
| Culex | 1 | 2017 | 66 | 0.16 | Why? |
| Herpes Zoster Vaccine | 1 | 2018 | 112 | 0.16 | Why? |
| Culicidae | 1 | 2017 | 239 | 0.15 | Why? |
| Stochastic Processes | 1 | 2017 | 369 | 0.14 | Why? |
| Communicable Disease Control | 3 | 2021 | 29620 | 0.14 | Why? |
| Chickenpox | 1 | 2018 | 194 | 0.14 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.13 | Why? |
| Immunization, Secondary | 2 | 2018 | 1649 | 0.12 | Why? |
| Climate | 1 | 2017 | 557 | 0.12 | Why? |
| Geography | 1 | 2018 | 1801 | 0.12 | Why? |
| Papillomavirus Vaccines | 1 | 2016 | 405 | 0.11 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.09 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.09 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.09 | Why? |
| Immunity, Herd | 1 | 2016 | 1011 | 0.09 | Why? |
| Schools | 2 | 2021 | 4187 | 0.09 | Why? |
| Seasons | 2 | 2017 | 4071 | 0.09 | Why? |
| Papillomavirus Infections | 1 | 2016 | 861 | 0.09 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.08 | Why? |
| Cough | 1 | 2021 | 4891 | 0.08 | Why? |
| Cities | 1 | 2018 | 4937 | 0.08 | Why? |
| Insect Vectors | 2 | 2017 | 227 | 0.07 | Why? |
| Quarantine | 3 | 2021 | 18418 | 0.07 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.07 | Why? |
| Immunization Programs | 1 | 2018 | 2006 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.07 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.07 | Why? |
| Contact Tracing | 2 | 2021 | 8448 | 0.06 | Why? |
| Norway | 2 | 2018 | 1004 | 0.06 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2017 | 2523 | 0.06 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.06 | Why? |
| Animals | 5 | 2017 | 78931 | 0.06 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Incidence | 3 | 2018 | 25622 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Brazil | 1 | 2018 | 12582 | 0.05 | Why? |
| Europe | 1 | 2017 | 12702 | 0.05 | Why? |
| Tachypnea | 1 | 2021 | 197 | 0.05 | Why? |
| Travel | 1 | 2017 | 7220 | 0.05 | Why? |
| Animal Distribution | 1 | 2017 | 23 | 0.05 | Why? |
| Humans | 16 | 2021 | 930598 | 0.04 | Why? |
| Pharyngitis | 1 | 2021 | 687 | 0.04 | Why? |
| Ethiopia | 1 | 2021 | 1222 | 0.04 | Why? |
| Chest Pain | 1 | 2021 | 578 | 0.04 | Why? |
| Competitive Behavior | 1 | 2017 | 111 | 0.04 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.03 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Female | 10 | 2021 | 380317 | 0.03 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.03 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Vaccines, Subunit | 1 | 2018 | 1088 | 0.03 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Child | 4 | 2021 | 70012 | 0.03 | Why? |
| Disease Eradication | 1 | 2016 | 581 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Models, Biological | 2 | 2017 | 4907 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Models, Statistical | 2 | 2017 | 5312 | 0.02 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2018 | 3231 | 0.02 | Why? |
| Pregnant Women | 1 | 2017 | 2535 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |